I like this one a lot. Strong revenues. Possible FDA approval for treosulfan (sp?) in august which could add another $150+ million in revenues plus nasdaq uplisting. Very undervalued
"Don't worry about the world coming to an end today. It's already tomorrow in Australia"
Market Data 
Markets 
AI
